Tali Voloshin

Preclinical Research Department, Novocure Ltd., Haifa, Israel

Affiliated withNovocure Ltd., Haifa, Israel

Research Area

Cancer Research

Biography

Tali Voloshin has not added Biography.
If you are Tali Voloshin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 57	2017

Other Publications

Article	Year
The angiogenic profile of colorectal cancer patients following open or laparoscopic colectomy. Cancer biology & therapy\| PubMed ID: 20814248	2010
G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist. Blood\| PubMed ID: 21685373	2011
Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice. Cancer research\| PubMed ID: 21978934	2011
Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugs. Stem cells (Dayton, Ohio)\| PubMed ID: 22782858	2012
The host immunological response to cancer therapy: An emerging concept in tumor biology. Experimental cell research\| PubMed ID: 23518388	2013
Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours. Carcinogenesis\| PubMed ID: 23828904	2013
Differential therapeutic effects of anti-VEGF-A antibody in different tumor models: implications for choosing appropriate tumor models for drug testing. Molecular cancer therapeutics\| PubMed ID: 24150126	2014
Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: a process regulated by osteopontin. International journal of cancer\| PubMed ID: 24347266	2014
Small but mighty: microparticles as mediators of tumor progression. Cancer microenvironment : official journal of the International Cancer Microenvironment Society\| PubMed ID: 24705797	2014
Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy. Neoplasia (New York, N.Y.)\| PubMed ID: 24957319	2014
Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo. Seminars in oncology\| PubMed ID: 25213867	2014
Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion Molecules. Molecular cancer therapeutics\| PubMed ID: 25852061	2015
Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis. Molecular cancer therapeutics\| PubMed ID: 25887886	2015
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells. Scientific reports\| PubMed ID: 26658786	2015
Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo. International journal of cancer\| PubMed ID: 27561100	2016